Cardiovascular Health Supplements Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cardiovascular Health Supplements Market size was around USD 9.1 billion in 2022 and is expected to reach USD 19.4 billion by 2032 with a CAGR of 7.5%. Increasing awareness towards a healthy lifestyle, ageing geriatric population, and growing research and development in the field of supplements will spur the market growth.
For instance, according to Centers for Disease Control and Prevention (CDC), an estimated 523 million people had some form cardiovascular disease in 2020. Therefore, health supplements become a vital component in the treatment & management of the heart function, to compensate for nutritional deficiencies caused by poor diet and lifestyle choices. Thus, widespread adoption of supplements is expected to foster the market progress.
Cardiovascular health supplements refer to a category of dietary supplements specifically formulated to support the proper functioning of the heart and circulatory system. These supplements typically contain various omega 3 fatty acids, vitamins & minerals, herbal nutraceuticals, coenzyme, and other natural or herbal ingredients that have beneficial effects on cardiovascular health.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cardiovascular Health Supplements Market Size in 2022: | USD 9.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 7.5 |
2023 Value Projection: | USD 19.4 Billion |
Historical Data for: | 2018 to 2022 |
No of Pages: | 140 |
Tables, Charts & Figures: | 264 |
Segments Covered: | Type, Form, Ingredient, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The COVID-19 pandemic had a positive impact on the global cardiovascular health supplements market. People with pre-existing cardiac diseases were shown to be severely affected by COVID-19, which made them more aware of the importance of heart health. The pandemic and related uncertainties led to increased stress and anxiety among many individuals. Therefore, few people turned to supplements, including those targeting heart health, to manage stress and its potential impact on their heart. Furthermore, the rise of telemedicine made it easier for people to consult healthcare professionals remotely and seek recommended supplements, including those for cardiovascular health.
Based on type, the global market is bifurcated into natural supplements and synthetic supplements. In the year 2022, natural supplements dominated the market with a substantial share of 69.3%. The factors such as ease of availability & accessibility, safety, and minimal side effects makes natural supplements the preferred choice for many individuals.
Based on form, the cardiovascular health supplements market is classified into solid and liquid. The solid segment is expected to reach USD 13.6 billion by the end of 2032.
Based on ingredient, the global cardiovascular health supplements market is classified into omega 3 fatty acid, vitamin & minerals, herbs, coenzyme Q10, and other ingredients. The omega 3 fatty acid segment accounted for USD 2.5 billion in 2022.
Based on distribution channel, the global cardiovascular health supplements market segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy segment dominated the market with a substantial share of 45.1%.
The North America cardiovascular health supplements market is expected to grow at 7.4% during the analysis period.
The players operating in this market have established themselves through, continuous research & development, and ensuring high-quality products. Herbalife International of America, Inc, Amway, and Nestle account for significant market share. These prominent players thrive through a combination of strategic approaches, diverse product portfolio, effective marketing strategies, market understanding, and regulatory compliance.
Market players operating in the cardiovascular health supplements is as mentioned below:
By Type, 2018 – 2032 (USD Million)
By Form, 2018 – 2032 (USD Million)
By Ingredient, 2018 – 2032 (USD Million)
By Distribution Channel, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries:
The global cardiovascular health supplements industry size was over USD 9 billion in 2022 and is expected to reach USD 19.4 billion by 2032, favored by the increasing awareness towards a healthy lifestyle, ageing geriatric population, and growing R&D in the field of supplements.
In the year 2022, natural supplements segment held a substantial market share of 69.3%. The factors such as ease of availability & accessibility, safety, and minimal side effects makes natural supplements the preferred choice for many individuals.
North America cardiovascular health supplements market is expected to grow at 7.4% during 2023 and 2032, as the region is equipped with highly advanced healthcare infrastructure, with robust pharmaceutical and supplement sectors, along with a surge in cardiovascular cases & related health challenges.
Herbalife International of America, Inc., Sanofi S.A., Nestle, Amway, Nature's Way Products, Inc, InVite Health, Nordic Naturals, Thorne HealthTech, Inc., GNC Holdings, Inc, NOW Health Group, Inc., and USANA Health Sciences.